HIT Consultant December 4, 2025
Syed Hamza Sohail

What You Should Know:

Paradigm Health’s acquisition of Flatiron Health’s Clinical Research Business, coupled with a long-term strategic partnership, marks a structural shift in how oncology trials are conducted and how patients across the country gain access to them.

– The deal brings together the nation’s most extensive tech-enabled oncology research network with an AI-powered trial infrastructure, creating a unified ecosystem designed to expand trial capacity, reduce operational friction and deliver more representative evidence.

Paradigm Health and Flatiron Health: Reshaping the U.S. Clinical Research Landscape

Through this transaction, Paradigm Health’s network now spans more than 25 academic medical centers and health systems, nearly 100 community oncology practices and more than 2.4 million patients nationwide. This expanded footprint allows trials...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Health System / Hospital, Mergers & Acquisitions / JV, Provider, Technology, Trends
HCA’s 2025 revenue surpassed $75B: 10 things to know
Emergency department metrics vs. reality: Why the numbers lie
Rural hospitals can realize big gains through strategic EHR optimization
The 250 best hospitals, according to Healthgrades
Why clinical excellence isn’t enough to sustain a physician-owned hospital

Share Article